Drug Channels Archive for January, 2026

Click a link below to view the mailing archive as if it had been sent to you.

2026-01-30 07:47		Drug Channels - From Cost Center to Insights Center: How Patient Support Will Go Beyond the Call in 2026
2026-01-27 07:47		Drug Channels News Roundup, January 2026: Cuban vs. Optum, McKesson's Biosimilar Play, States vs. Accumulators, 340B Windfalls, and Ozempic Ads
2026-01-23 07:57		Drug Channels - New Drug Launches in a Self-Pay World: Why Access Strategy Matters as Much as Innovation
2026-01-22 07:51		Drug Channels - The Big Three PBMs' 2026 Formulary Exclusions: MFP, Private Label Biosimilars, and Direct-to-Patient Threats for PBMs
2026-01-14 07:47		Drug Channels - The Net Pricing Revolution in the Drug Channel: What's Deflating the Gross-to-Net Bubble
2026-01-13 07:47		NEW: The Drug Channels 2026 Video Webinar Series
2026-01-09 07:47		Drug Channels - Targeted Reach, Tighter Relationships: Why Rare Disease Launches Are Different
2026-01-07 07:47		Drug Channels - U.S. Brand-Name Drug Prices Fell in 2025 as the Net Pricing Drug Channel Emerges
2026-01-06 07:51		Drug Channels Leadership Forum 2026: Request an Invitation Before It's Too Late!